{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T23:31:35Z","timestamp":1722382295426},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Biology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.repbio.2024.100879","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:54:41Z","timestamp":1711515281000},"page":"100879","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["IVF outcomes pre- and post-anti-COVID-19 vaccination \u2013 Are there any differences?"],"prefix":"10.1016","volume":"24","author":[{"given":"Marina Arselia","family":"Fradkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heli","family":"Alexandroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talia","family":"Eldar-Geva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido","family":"Ben-Ami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repbio.2024.100879_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.repbio.2024.100879_bib2","unstructured":"WHO [Web, cited 2023 Dec 2]. Available from: \u3008https:\/\/covid19.who.int\/\u3009."},{"key":"10.1016\/j.repbio.2024.100879_bib3","unstructured":"Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic, 5 May 2023, available from: \u3008https:\/\/www.who.int\/\u3009."},{"key":"10.1016\/j.repbio.2024.100879_bib4","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repbio.2024.100879_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.repbio.2024.100879_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/and.14361","article-title":"Fear about adverse effect on fertility is a major cause of COVID\u201019 vaccine hesitancy in the United States.","volume":"54","author":"Diaz","year":"2022","journal-title":"Andrologia"},{"key":"10.1016\/j.repbio.2024.100879_bib7","unstructured":"Wodarg W.S.D.. 2020, December 1. Petition\/motion for administrative\/regulatory action regarding confirmation of efficacy end points and use of data in connection with the following clinical trial (s): phase III-eudract number: 2020\u2013002641-2. corona-ausschuss.de. https:\/\/www.wodarg.com\/app\/download\/9033912514\/Wodarg_Yeadon_EMA_Petition_Pfizer_Trial_FINAL_01DEC2020_signed_with_Exhibits_geschwa%CC%88rzt.pdf? t=1606870652."},{"key":"10.1016\/j.repbio.2024.100879_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.rbmo.2020.09.020","article-title":"Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age","volume":"42","author":"Li","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.repbio.2024.100879_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100604","article-title":"Impaired spermatogenesis in COVID-19 patients","volume":"28","author":"Li","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.repbio.2024.100879_bib10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jmv.26259","article-title":"Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients","volume":"93","author":"Ma","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.repbio.2024.100879_bib11","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.107.108944","article-title":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents","volume":"51","author":"Hern\u00e1ndez Prada","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.repbio.2024.100879_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/humrep\/deab238","article-title":"Effects of COVID-19 and mRNA vaccines on human fertility","volume":"37","author":"Chen","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.repbio.2024.100879_bib13","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repbio.2024.100879_bib14","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/humrep\/deab182","article-title":"Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination","volume":"36","author":"Bentov","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.repbio.2024.100879_bib15","doi-asserted-by":"crossref","DOI":"10.2196\/48511","article-title":"Effects of SARS-CoV-2 Vaccines on Sperm Quality: Systematic Review","author":"Li","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.repbio.2024.100879_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-021-00757-6","article-title":"Does mRNA SARS-CoV-2 vaccine influence patients\u2019 performance during IVF-ET cycle?","volume":"19","author":"Orvieto","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.repbio.2024.100879_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.rbmo.2022.01.008","article-title":"The BNT162b2 mRNA Covid-19 vaccine does not impair sperm parameters","volume":"44","author":"Safrai","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.repbio.2024.100879_bib18","unstructured":"Israel [Web, cited 2023 Dec 3]. Available from: \u3008https:\/\/www.who.int\/countries\/isr\/\u3009."},{"key":"10.1016\/j.repbio.2024.100879_bib19","unstructured":"Patient management and clinical recommendations during the Coronavirus (COVID-19) pandermic, Update No. 20- April 20, 2022, American society for reproductive medicine (ASRM), [Web, cited 2023 Dec 5]. Available from: \u3008https:\/\/www.asrm.org\/practice-guidance\/covid-19-resources\/asrm-patient-management-and-clinical-recommendations-during-the-coronavirus-covid-19-pandemic\/\u3009."},{"key":"10.1016\/j.repbio.2024.100879_bib20","unstructured":"COVID-19 Vaccine policies for pregnant and lactating people worldwide, Israel Society of Obstetrics and Gynecology [Web, cited 2023 Dec 5]. Available from: \u3008https:\/\/www.comitglobal.org\/organization\/recExelFje5ANdpOP\u3009."},{"key":"10.1016\/j.repbio.2024.100879_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmj.p153","article-title":"Covid-19: What do we know about XBB.1.5 and should we be worried?","volume":"380","author":"Mahase","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.repbio.2024.100879_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2023.2143347","article-title":"Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic","volume":"22","author":"Solante","year":"2023","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.repbio.2024.100879_bib23","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1016\/j.vaccine.2023.07.071","article-title":"Protection against symptomatic SARS-CoV-2 BA.5 infection conferred by the Pfizer-BioNTech Original\/BA.4-5 bivalent vaccine compared to the mRNA Original (ancestral) monovalent vaccines - a matched cohort study in France","volume":"41","author":"Auvigne","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.repbio.2024.100879_bib24","unstructured":"Moderna Clinical Trial Data Confirm Its Updated COVID-19 Vaccine Generates Robust Immune Response in Humans Against Widely Circulating Variants [Web, cited 2023 December 5]; Available from: \u3008https:\/\/investors.modernatx.com\/news\/news-details\/2023\/Moderna-Clinical-Trial-Data-Confirm-Its-Updated-COVID-19-Vaccine-Generates-Robust-Immune-Response-in-Humans-Against-Widely-Circulating-Variants\/default.aspx\u3009."},{"key":"10.1016\/j.repbio.2024.100879_bib25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4161\/hv.24657","article-title":"Vaccine hesitancy: an overview","volume":"9","author":"Dub\u00e9","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.repbio.2024.100879_bib26","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1016\/j.vaccine.2022.09.019","article-title":"The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis","volume":"40","author":"Za\u00e7e","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.repbio.2024.100879_bib27","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/humrep\/deaa137","article-title":"Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve","volume":"35","author":"Romanski","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.repbio.2024.100879_bib28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.fertnstert.2012.11.044","article-title":"Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?","volume":"99","author":"Reichman","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2024.100879_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/09513590400021094","article-title":"Consecutive cycles in in vitro fertilization--embryo transfer","volume":"20","author":"Doldi","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.repbio.2024.100879_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/01443615.2014.960830","article-title":"The impact of the time interval on in-vitro fertilisation success after failure of the first attempt","volume":"35","author":"Bayoglu Tekin","year":"2015","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.repbio.2024.100879_bib31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3109\/02656736.2012.724516","article-title":"Fever in women may interfere with follicular development during controlled ovarian stimulation","volume":"28","author":"Awwad","year":"2012","journal-title":"Int J Hyperth"},{"key":"10.1016\/j.repbio.2024.100879_bib32","first-page":"1","article-title":"Role of Inflammaging on the Reproductive Function and Pregnancy","author":"Zavatta","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.repbio.2024.100879_bib33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/humupd\/dmaa012","article-title":"C-reactive protein and ART outcomes: a systematic review","volume":"26","author":"Brouillet","year":"2020","journal-title":"Hum Reprod Update"}],"container-title":["Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X24000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X24000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T08:33:27Z","timestamp":1717662807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1642431X24000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1642431X24000251"],"URL":"https:\/\/doi.org\/10.1016\/j.repbio.2024.100879","relation":{},"ISSN":["1642-431X"],"issn-type":[{"value":"1642-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IVF outcomes pre- and post-anti-COVID-19 vaccination \u2013 Are there any differences?","name":"articletitle","label":"Article Title"},{"value":"Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repbio.2024.100879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Society for Biology of Reproduction & the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100879"}}